Marie Martin, PhD, MEd, assistant professor of Health Policy, has been named associate director for Education and Training in the Vanderbilt Institute for Global Health (VIGH). Marie Martin, PhD, MEdMartin stepped into the role at the beginning of the fiscal year, succeeding Douglas Heimburger, MD, MS, who will focus his time on leading projects with grant funding from the Fogarty International Center of the National Institutes of Health (NIH). Heimburger started in 2009 as associate director of Education and Training.
The Vanderbilt Institute for Global Health, with Aminu Kano Teaching Hospital, will conduct a 60-site cluster randomized clinical trial in three cities in northern Nigeria to determine the efficacy of shifting childhood epilepsy care to epilepsy-trained community health extension workers with a five-year $5.9 million federal grant, “Bridging the Childhood Epilepsy Treatment Gap in Africa (BRIDGE),” from National Institute of Neurological Disorders and Stroke of the National Institutes of Health. Edwin Trevathan, M.D., M.P.H., Amos Christie Chair in Global Health, Professor of Pediatrics and
The Vanderbilt Institute for Global Health (VIGH) has been awarded a five-year, $1.2 million federal grant from the Fogarty International Center of the National Institutes of Health to evaluate and build a research capacity program in implementation science and clinical trial management to address Ebola, Lassa fever and other viral hemorrhagic fevers (VHF) in Sierra Leone. The Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL) will address gaps and improve existing research capacity at in-country partner institutions.
"Among people with HIV in Latin America, those diagnosed with tuberculosis (TB) at an initial clinic visit were about twice as likely to die within 10 years as people not initially diagnosed with TB, according to findings from a large observational study. This increased risk persisted despite the availability of TB treatment and mirrored patterns seen previously in HIV-negative populations, according to research supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
VIGH faculty, staff, and students presented at the 2019 Consortium of Universities in Global Health (CUGH) Conference on March 9-10 in Chicago. The 10th annual conference was focused on Translation and Implementation for Impact in Global Health. The VIGH team presented on a range of topics, from the development of a research methods for a nurse anesthetist program in Kenya to nutrition education outreach in the Western Highlands of Guatemala.
Students in the spring semester of their second year of the Vanderbilt MPH program present their thesis to mentors, colleagues, fellow students, and guests. This year, the following students in the Global Health track will present their thesis findings. Presentations will take place in MPH Classroom #2600, Village at Vanderbilt (1500 21st Avenue South). See below for a list of Global Health students and their thesis topics. RSVP one week before the presentation(s) you wish to attend.
The UNZA-Vanderbilt Training Partnership for HIV-Nutrition-Metabolic Research (UVP) continues a longstanding training collaboration between the University of Zambia School of Medicine/University Teaching Hospital (UNZA/UTH), and the Vanderbilt Institute for Global Health (VIGH). Dr. Douglas Heimburger, Associate Director for Education and Training for VIGH and Dr. Selestine Nzala, Head, Department of Medical Education, University of Zambia School of Medicine serve as Principal Investigators.
This year, the Vanderbilt School of Medicine Global Health Organization will present World Health Week during Monday, February 25 - Friday, March 1. World Health Week is committed to spreading awareness about global health, and this year's theme is "Global Health and Anesthesia." Events include lunchtime talks and a global health symposium one evening. Lunch is offered with RSVP. Download the flyer.
Research led by Vanderbilt investigators found nearly 40% of HIV-exposed infants in low‐ and middle‐income countries (LMIC) were not in care at 18 months of age or had died. Despite the availability and progress of HIV prevention of mother-to-child transmission (PMTCT) programs which includes postpartum follow-up of HIV-positive mothers and their HIV-exposed infants, many infants do not remain engaged in early infant diagnosis (EID) services that are essential to optimal health outcomes.
Mark Newton, M.D., FAAP, Professor of Clinical Anesthesiology, Director of Vanderbilt International Anesthesia, recently co-wrote an opinion piece for Devex, a media website for the global development community. The opinion piece focuses on the growing need of anesthesia providers across the world. In particular, low- and middle-income countries (LMICs) have the fewest number of anesthesia providers.
In 2017, according to UNAIDS, more than 90% of HIV-positive pregnant women accessed antiretroviral (ART) medicines to prevent mother-to child transmission of HIV in Southern Africa, and recent research suggests access and adherence to ART remains high during pregnancy due in part to the scale up of national antenatal (ANC) and ART care clinics. Engagement in HIV care after delivery, however, can be challenging.
Vanderbilt Medicine MD/MPH dual-degree candidate, Justin Banerdt, completed his fellowship year as a VECD Fogarty Global Health Fellow in July 2018. He spent his year conducting research focused on the prevalence and outcomes of delirium in a critically ill patient population with a high burden of HIV/AIDS at the University Teaching Hospital (UTH) in Lusaka, Zambia. UTH is the teaching hospital affiliated with the University of Zambia School of Medicine (UNZA).
VIGH affiliated faculty member Brian L. Heuser, Ed.D., M.T.S., recently received the Thomas Jefferson Award "for distinguished service to Vanderbilt through extraordinary contributions as a member of the faculty in the councils and government of the university" at the Vanderbilt Fall Faculty Assembly on August 23. Dr.